Nephritis  >>  BIIB023  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIIB023 / Biogen
ATLAS, NCT01499355 / 2011-002159-32: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis

Terminated
2
276
US, Europe, RoW
BIIB023, Placebo, mycophenolate mofetil, MMF, Cellcept, oral corticosteroids
Biogen
Lupus Nephritis
12/15
12/15
NCT01930890 / 2013-000594-69: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

Terminated
2
87
US, Europe, RoW
BIIB023, mycophenolate mofetil, MMF, Cellcept, oral corticosteroids
Biogen
Lupus Nephritis
01/16
01/16

Download Options